| ambaf | 2-[N-(1Hbenzimidazol-2-ylmethyl)ethanimidoyl]aniline |
| amphen | 5-amine-1,10-phenanthroline |
| apyepy | 2-(pyridin-2-yl)-N-[1-(pyridin-2-yl)ethylidene]-ethanamine |
| Bphen | 4,7-diphenyl-1,10-phenanthroline |
| bib | 1,3-bis(imidazol-1-yl)benzene |
| bip | 3,5-bis(1-imidazoly)pyridine |
| bpy | 2,2-bipyridine |
| CT | calf thymus |
| cisplatin | cis-diamminedichloroplatinum(II) |
| dmoPTA | 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane |
| H2bdc | 1,4-dicarboxybenzene |
| H2tib | 1,3,5-tris(1-imidazolyl)benzene |
| HMFN | mefenamic acid |
| Hnor | norharmane |
| HNPR | naproxen |
| HPV | human papilloma virus |
| HSA | human serum albumin |
| IC50 | concentration affording 50% of inhibition |
| Ida | iminodiacetate |
| MOCs | metal-organic chains |
| NaNPR | sodium naproxen |
| NH2-H2bdc | 2-amino-1,4-dicarboxybenzene |
| NSAID | non-steroidal anti-inflammatory drug |
| NVC | novocidin |
| Pcs | phthalocyanines |
| Pdc | 2,6-pyridine dicarboxylate |
| PDT | photodynamic therapy |
| phen | 1,10-phenantroline |
| phendione | 1,10-phenanthroline-5,6-dione |
| ROS | reactive oxygen species |
| Sal-Gly | N-salicylideneglycinate |
| SARs | structure-activity relationships |